Further Information
EBAG9, estrogen receptor binding site associated, antigen, 9, HGNC:3123, EB9, PDAF, RCAS1, cancer associated surface antigen, estrogen receptor binding site associated antigen 9
WB: 1:500 - 1:2000
IHC: 1:50 - 1:200
This gene was identified as an estrogen-responsive gene. Regulation of transcription by estrogen is mediated by estrogen receptor, which binds to the estrogen-responsive element found in the 5'-flanking region of this gene. The encoded protein is a tumor-associated antigen that is expressed at high frequency in a variety of cancers. Alternate splicing results in multiple transcript variants. A pseudogene of this gene has been defined on chromosome 10.
PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
batch dependent
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Recombinant fusion protein containing a sequence corresponding to amino acids 28-213 of human EBAG9 (NP_004206.1).
9166
estrogen receptor binding site associated, antigen, 9
EBAG9
Homo sapiens
Liquid
PREDICTED MOLECULAR WEIGHT:
Observed: 28kDa
Affinity purification
Apoptosis, Cancer, Cell Cycle, Growth Factors, Immunology, Signal Transduction
O00559
Optimal dilutions for each application to be determined by the researcher.